Middle East and Africa Cardiovascular Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device [Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others], Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others), and End-User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers)

The Middle East & Africa cardiovascular devices market is expected to reach US$ 4,867.10 million by 2028 from US$ 3,184.65 million in 2021. The market is estimated to grow at a CAGR of 6.2% from 2021 to 2028.

The rapidly increasing prevalence of Cardiovascular Devices is raising the demand for technically advanced devices for diagnosing and treating patients with effective and efficient care. The market for the mitral valve is likely to experience continuous developments in mitral valve repair and percutaneous mitral valve replacement procedures. In October 2020, Medtronic launched the Azure pacemaker with BlueSync technology—it is India's first and only pacemaker capable of establishing communications directly with patients' cellphones and tablets. For instance, NewPace Ltd. (Israel) has developed implantable string subcutaneous defibrillators (ISSD) with the help of researchers at Na Homolce Hospital in Prague, Czech Republic. ISSD is a less invasive device that can prevent sudden deaths caused by cardiac conditions. The device does not require a metal pulse generator pocket. ISSD takes 20 minutes for implantation, and it can be connected to a smartphone. Thus, such advanced devices are

likely to lead to new trends in the MEA cardiovascular devices market in the future. The Middle East & Africa Cardiovascular Devices market is expected to grow at a good CAGR during the forecast period.

Middle East & Africa Cardiovascular Devices Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Cardiovascular Devices Market Segmentation     

The Middle East & Africa cardiovascular devices market is segmented into device, application, end user, and country. Based on device, the market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment dominated the market in 2020. In terms of application, the market is segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease, and others. The coronary heart disease segment dominated the market in 2020. Based on end user, the market is segmented into hospitals, ambulatory surgery centers, and cardiac centers. The hospitals segment dominated the market in 2020. Based on country, the Middle East & Africa cardiovascular devices market is segmented into Saudi Arabia, UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa cardiovascular devices market in 2020.

Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips N.V, Siemens Healthineers AG, BD, B. Braun Melsungen AG,  and Edwards Lifesciences Corporation are among the leading companies in the Middle East & Africa cardiovascular devices market.

1. Medtronic.
2. Boston Scientific Corporation.
3. Abbott.
4. Jhonson and Jhonson Service Inc.
5. General Electric Company.
6. Koninlijke Philips N.V.
7. Siemens Healthineers AG.
8. BD.
9. B.Bruna melsungen AG.
10. Edwards Lifesciences Corporation. 

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Cardiovascular Devices market forecast.   
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa Cardiovascular Devices market forecast, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the cardiovascular devices market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.